Founded by entrepreneurs, The Refiners is a San Francisco-based seed fund program dedicated to supporting world-class international startups in Silicon Valley. Over three months, selected startups receive funding, networking opportunities, and mentorship to scale globally.
Snipfeed, founded in 2017 and based in San Francisco, California, develops an innovative platform designed specifically for content creators. By enabling users to build their storefronts directly on social media, Snipfeed consolidates essential monetization tools into a single interface. This allows creators to easily monetize their audience through on-demand content, direct interactions, tips, and e-commerce options. Additionally, Snipfeed provides a comprehensive dashboard that integrates various third-party tools, including analytics and financial resources, to help creators optimize and grow their businesses efficiently. Through its AI-driven recommendation system, Snipfeed delivers personalized information to users via chat, enhancing the overall user experience.
Elva
Pre Seed Round in 2018
Elva is a company that designs and develops innovative wearable technology, focusing on smart watches and medication monitoring devices. Founded in 2013 and based in San Francisco, Elva offers the Uband, a smart watch that enables users to view notifications, track activities, and scan barcodes for medication management. With seven granted patents, Elva's devices facilitate remote monitoring of medication adherence, helping families and healthcare providers ensure that patients are taking the correct medications at the appropriate times. The Uband also functions as a medical alert device, providing users with a safety net in case of emergencies. Formerly known as Practech Inc., the company rebranded to Elva in May 2018, reflecting its commitment to enhancing health and wellness through smart technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.